Atos partners with Eupry to offer a Compliance Monitoring service for Covid-19 vaccine delivery

Paris, France - 21 December 2020 – Atos has partnered with Eupry, a Danish startup specializing in automatic storage compliance, to build a "Vaccine Logistics Monitoring as-a-Service” solution. This will enable public authorities and pharmaceutical and logistics companies to effectively manage the supply chain of large-scale distribution of Covid-19 vaccines, as well as other vaccines in the future, to ensure compliance with local regulations, good manufacturing and distribution practices and other complex requirements, such as temperature.

Over the coming weeks, millions of Covid-19 vaccine doses will be distributed to over 100 countries simultaneously. Logistically, the challenge is two-fold. As Covid-19 vaccines have serious temperature constraints that need to be rigorously monitored continuously throughout the logistics process, distribution needs to both manage multiple transportation and storage stages in thousands of different points across each country, as well as maintaining the environmental parameters within the regulation-compliant ranges, which in some cases exceed -70 ºC, depending on the vaccine.

Combining Eupry’s wireless data loggers with Atos’ long-standing expertise in automation and monitoring together with its ability to successfully implement large projects on a global scale, the joint solution safeguards the logistics process end-to-end via a single platform. Eupry’s loggers monitor temperatures from -200°C to 800°C, as well as differential pressure, humidity and carbon dioxide across the logistics chain (fridge, freezer, transport and storage).

The joint solution offers a fully automated service which optimizes resources and eliminates the risk of error and breach of compliance, including:

• Monitoring, alerting and maintaining transportation & shipment compliance, tailored to customers’ needs
• The solution is IT-validated
• Compliant towards FDA PART11
• Data loggers are shipped with ISO17025 calibrated (accredited) certificates
• Built-in, end-to-end traceability with location tracking
• Scalability from one up to thousands of units
• Robust and proven security solutions backed by Atos’ expertise

Niels Thomsen, Group Vice President, Global Head of the Insight (IoT & AI) practice at Atos said: "The toll of Covid-19 on all aspects of our lives has been devastating and the vaccines offers us hope for a better 2021. Organizing their distribution all over the world in such a short time will be an extremely complex operation and we are proud to contribute, at our level, by partnering with Eupry to offer a solution that can simplify the work of those directly involved.”

Christian Herschend Jacobsen, CEO at Eupry said: "It is amazing how fast the life science industry today can develop hope for a brighter future. From our experience with UNICEF we know it is a major task to manufacture and distribute vaccines to billions of people world-wide and this is still ahead of us. It’s essential that we do not waste or damage vaccines due to wrong storage conditions. We need to utilize technology to free already overburdened health personal from manual processes including quality assurance. We – Eupry - started our journey back in 2012 helping Unicef and Clinton Health Access Initiative in their pursuit to deliver better quality in vaccine distribution, and we managed to make a compliance service exactly for this kind of situation.”

To learn more: https://atos.net/en/solutions/atos-codex-connected-intelligence/atos-codex-iot

***

About Atos
Atos is a global leader in digital transformation with 110,000 employees and annual revenue of € 12 billion. European number one in cybersecurity, cloud and high performance computing, the group provides tailored end-to-end solutions for all industries in 73 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos operates under the brands Atos and Atos|Syntel. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index.

The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

About Eupry
Eupry is a Danish tech startup with a unique international profile within the IOT industry. Eupry has proven to reduce compliance work by 70% in pharma companies, hospitals, laboratories, and GDP logistics, because of a comprehensive focus on compliance optimization and thermal calibration automation. Eupry runs a fully automated ISO17025 accredited laboratory and has developed a wide range of solutions including various wireless sensors, software applications and calibration solutions. In Eupry we provide clients with a full package of compliance services to take care of storage such as thermal mapping, qualifications, automated calibrations, temperature and humidity monitoring. Eupry is powered by a strong founding team, dedicated staff, and funded by the Danish Growth Foundation.
Eupry works to free bright minded people from manual quality assurance processes by using our unlimited passion for technology to create the world's simplest compliance experience - for storing sensitive assets in the life science and health industry.

Press contact: Marion Delmas | marion.delmas@atos.net | +33 6 37 63 91 99

Attachment

• PR - Atos partners with Eupry to offer a Compliance Monitoring service for Covid-19 vaccine delivery